Island Pharmaceuticals Ltd - De-risking the commercial path
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company has made two recent...
Island Pharmaceuticals Ltd - Animal Rule allowed - First de-risking event down
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company on 17 November 2025 released...
Island Pharmaceuticals Ltd - Clinical Proof, Policy Pull
It is currently at clinical-stage and focused on two key antiviral assets – Galidesivir (a broad-spectrum RNA antiviral initially for Marburg) and...
No more insights